SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-1 - General form for registration of securities under the Securities Act of 1933:
SEC Accession No. 0001493152-20-011646
Filing Date
2020-06-23
Accepted
2020-06-23 16:01:22
Documents
17

Document Format Files

Seq Description Document Type Size
1 forms-1.htm S-1 1351290
2 ex3-13.htm EX-3.13 9388
3 ex5-1.htm EX-5.1 1112
4 ex23-1.htm EX-23.1 3882
5 logo_001.jpg GRAPHIC 7830
6 ex13-1_001.jpg GRAPHIC 390157
7 ex13-1_002.jpg GRAPHIC 446481
8 ex13-1_003.jpg GRAPHIC 453876
9 ex13-1_004.jpg GRAPHIC 684585
10 ex13-1_005.jpg GRAPHIC 614149
11 ex13-1_006.jpg GRAPHIC 581911
12 ex13-1_007.jpg GRAPHIC 709089
13 ex13-1_008.jpg GRAPHIC 492158
14 ex13-1_009.jpg GRAPHIC 155414
15 ex13-1_010.jpg GRAPHIC 318041
16 ex13-1_011.jpg GRAPHIC 220104
17 ex5-1_001.jpg GRAPHIC 125193
  Complete submission text file 0001493152-20-011646.txt   8526418
Mailing Address 6320 CANOGA AVENUE 15TH FLOOR WOODLAND HILLS CA 91367
Business Address 6320 CANOGA AVENUE 15TH FLOOR WOODLAND HILLS CA 91367 (800) 489-4774
ENDONOVO THERAPEUTICS, INC. (Filer) CIK: 0001528172 (see all company filings)

IRS No.: 452552528 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-1 | Act: 33 | File No.: 333-239384 | Film No.: 20981917
SIC: 2834 Pharmaceutical Preparations